{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T09:09:14Z","timestamp":1788858554273,"version":"build-2803163510"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2017A030313809"],"award-info":[{"award-number":["2017A030313809"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81471363"],"award-info":[{"award-number":["81471363"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81571310"],"award-info":[{"award-number":["81571310"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81630033"],"award-info":[{"award-number":["81630033"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Basic Research Program of China","doi-asserted-by":"publisher","award":["2016YFC1306900"],"award-info":[{"award-number":["2016YFC1306900"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.schres.2019.08.005","type":"journal-article","created":{"date-parts":[[2019,8,12]],"date-time":"2019-08-12T08:01:29Z","timestamp":1565596889000},"page":"92-98","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":77,"special_numbering":"C","title":["The effect of minocycline on amelioration of cognitive deficits and pro-inflammatory cytokines levels in patients with schizophrenia"],"prefix":"10.1016","volume":"212","author":[{"given":"Lulu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbo","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rengrong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas R.","family":"Kosten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-Yang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingping","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2019.08.005_bb0005","first-page":"350","article-title":"Do cognitive deficits predict negative emotionality and aggression in schizophrenia?","volume":"259","author":"Ahmed","year":"2018","journal-title":"Schizophr. Res."},{"issue":"1","key":"10.1016\/j.schres.2019.08.005_bb0010","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.schres.2014.03.035","article-title":"Glial cells as key players in schizophrenia pathology: recent insights and concepts of therapy","volume":"161","author":"Bernstein","year":"2014","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2019.08.005_bb0015","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1189\/jlb.0212100","article-title":"The immune theory of psychiatric diseases: a key role for activated microglia and circulating monocytes","volume":"92","author":"Beumer","year":"2012","journal-title":"J.\u00a0Leukoc. Biol."},{"issue":"1","key":"10.1016\/j.schres.2019.08.005_bb0020","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/glia.22372","article-title":"Microglia as modulators of cognition and neuropsychiatric disorders","volume":"61","author":"Blank","year":"2013","journal-title":"Glia"},{"issue":"9","key":"10.1016\/j.schres.2019.08.005_bb0025","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1177\/0269881112444941","article-title":"Minocycline benefits negative symptoms in early schizophrenia: a randomized double-blind placebo-controlled clinical trial in patients on standard treatment","volume":"26","author":"Chaudhry","year":"2012","journal-title":"J.\u00a0Psychopharmacol."},{"key":"10.1016\/j.schres.2019.08.005_bb0030","first-page":"1","article-title":"An activated set point of T-cell and monocyte inflammatory networks in recent-onset schizophrenia patients involves both pro- and anti-inflammatory forces","volume":"24","author":"Drexhage","year":"2011","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"7","key":"10.1016\/j.schres.2019.08.005_bb0035","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1586\/14737175.7.7.789","article-title":"Inflammation and schizophrenia","volume":"7","author":"Fan","year":"2007","journal-title":"Expert. Rev. Neurother."},{"issue":"2","key":"10.1016\/j.schres.2019.08.005_bb0040","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/mp.2012.110","article-title":"Increased inflammatory markers identified in the dorsolateral prefrontal cortex of individuals with schizophrenia","volume":"18","author":"Fillman","year":"2013","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.schres.2019.08.005_bb0045","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1038\/mp.2016.3","article-title":"A\u00a0meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression","volume":"21","author":"Goldsmith","year":"2016","journal-title":"Mol. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2019.08.005_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2004.09.006","article-title":"The MATRICS initiative: developing a consensus cognitive battery for clinical trials","volume":"72","author":"Green","year":"2004","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2019.08.005_bb0055","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.bbi.2009.10.002","article-title":"Sustained hippocampal IL-1beta overexpression impairs contextual and spatial memory in transgenic mice","volume":"24","author":"Hein","year":"2010","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.schres.2019.08.005_bb0060","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1093\/cercor\/bhr229","article-title":"Evidence that microglia mediate the neurobiological effects of chronic psychological stress on the medial prefrontal cortex","volume":"22","author":"Hinwood","year":"2012","journal-title":"Cereb. Cortex"},{"issue":"4","key":"10.1016\/j.schres.2019.08.005_bb0065","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.biopsych.2013.06.010","article-title":"Immune system disturbances in schizophrenia","volume":"75","author":"Horvath","year":"2014","journal-title":"Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.schres.2019.08.005_bb0070","first-page":"374","article-title":"Adjunctive minocycline in clozapine-treated schizophrenia patients with persistent symptoms","volume":"35","author":"Kelly","year":"2015","journal-title":"JClinPsychopharmacol"},{"issue":"2","key":"10.1016\/j.schres.2019.08.005_bb0075","doi-asserted-by":"crossref","first-page":"138","DOI":"10.4088\/JCP.08m04666yel","article-title":"A\u00a0double-blind, randomized study of minocycline for the treatment of negative and cognitive symptoms in early-phase schizophrenia","volume":"71","author":"Levkovitz","year":"2010","journal-title":"J\u00a0Clin Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2019.08.005_bb0080","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.schres.2013.02.009","article-title":"Clinical symptoms, mainly negative symptoms, mediate the influence of neurocognition and social cognition on functional outcome of schizophrenia","volume":"146","author":"Lin","year":"2013","journal-title":"Schizophr. Res."},{"issue":"1\u20133","key":"10.1016\/j.schres.2019.08.005_bb0085","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.schres.2014.01.011","article-title":"Minocycline supplementation for treatment of negative symptoms in early-phase schizophrenia: a double blind, randomized, controlled trial","volume":"153","author":"Liu","year":"2014","journal-title":"Schizophr. Res."},{"issue":"4","key":"10.1016\/j.schres.2019.08.005_bb0090","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1440-1819.2012.02354.x","article-title":"Cytokines in schizophrenia: possible role of anti-inflammatory medications in clinical and preclinical stages","volume":"66","author":"Mansur","year":"2012","journal-title":"Psychiatry Clin. Neurosci."},{"issue":"7","key":"10.1016\/j.schres.2019.08.005_bb0095","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.biopsych.2011.04.013","article-title":"Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects","volume":"70","author":"Miller","year":"2011","journal-title":"Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2019.08.005_bb0100","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s00213-007-0955-0","article-title":"Improvement by minocycline of methamphetamine-induced impairment of recognition memory in mice","volume":"196","author":"Mizoguchi","year":"2008","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1016\/j.schres.2019.08.005_bb0105","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1440-1819.2009.01945.x","article-title":"Cytokines and schizophrenia: microglia hypothesis of schizophrenia","volume":"63","author":"Monji","year":"2009","journal-title":"Psychiatry Clin. Neurosci."},{"issue":"5","key":"10.1016\/j.schres.2019.08.005_bb0110","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.pnpbp.2011.12.002","article-title":"Neuroinflammation in schizophrenia especially focused on the role of microglia","volume":"42","author":"Monji","year":"2013","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.schres.2019.08.005_bb0115","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1016\/j.cell.2013.11.030","article-title":"Microglia promote learning-dependent synapse formation through brain-derived neurotrophic factor","volume":"155","author":"Parkhurst","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.schres.2019.08.005_bb0120","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1001\/archneurol.2010.191","article-title":"Prospects for minocycline neuroprotection","volume":"67","author":"Plane","year":"2010","journal-title":"Arch. Neurol."},{"issue":"2","key":"10.1016\/j.schres.2019.08.005_bb0125","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1176\/appi.ajp.159.2.227","article-title":"A\u00a0PET study of the pathophysiology of negative symptoms in schizophrenia. Positron emission tomography","volume":"159","author":"Potkin","year":"2002","journal-title":"Am. J. Psychiatry"},{"issue":"8","key":"10.1016\/j.schres.2019.08.005_bb0130","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.biopsych.2007.09.024","article-title":"Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review","volume":"63","author":"Potvin","year":"2008","journal-title":"Biol. Psychiatry"},{"issue":"1\u20133","key":"10.1016\/j.schres.2019.08.005_bb0135","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.schres.2010.09.023","article-title":"Assessment of negative symptoms and depression in schizophrenia: revision of the SANS and how it relates to the PANSS and CDSS","volume":"126","author":"Rabany","year":"2011","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2019.08.005_bb0140","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.mehy.2015.12.021","article-title":"Cortical gray matter loss in schizophrenia: could microglia be the culprit?","volume":"88","author":"Racki","year":"2016","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.schres.2019.08.005_bb0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.psychres.2016.08.062","article-title":"Schizophrenia, smoking status, and performance on the matrics Cognitive Consensus Battery","volume":"246","author":"Reed","year":"2016","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.schres.2019.08.005_bb0150","doi-asserted-by":"crossref","first-page":"16241","DOI":"10.1523\/JNEUROSCI.3667-11.2011","article-title":"CX3CR1 deficiency leads to impairment of hippocampal cognitive function and synaptic plasticity","volume":"31","author":"Rogers","year":"2011","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.schres.2019.08.005_bb0160","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1189\/jlb.0608385","article-title":"Microglia: gatekeepers of central nervous system immunology","volume":"85","author":"Tambuyzer","year":"2009","journal-title":"J.\u00a0Leukoc. Biol."},{"issue":"6","key":"10.1016\/j.schres.2019.08.005_bb0165","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1113\/JP272134","article-title":"Microglia across the lifespan: from origin to function in brain development, plasticity and cognition","volume":"595","author":"Tay","year":"2017","journal-title":"J.\u00a0Physiol."},{"issue":"2\u20133","key":"10.1016\/j.schres.2019.08.005_bb0170","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.schres.2009.03.035","article-title":"Symptoms as mediators of the relationship between neurocognition and functional outcome in schizophrenia: a meta-analysis","volume":"113","author":"Ventura","year":"2009","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2019.08.005_bb0175","doi-asserted-by":"crossref","first-page":"15511","DOI":"10.1523\/JNEUROSCI.3688-11.2011","article-title":"Microglia and memory: modulation by early-life infection","volume":"31","author":"Williamson","year":"2011","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.schres.2019.08.005_bb0180","doi-asserted-by":"crossref","unstructured":"Wohleb ES, Hanke ML, Corona AW, Powell ND, Stiner LM, Bailey MT, Nelson RJ, Godbout JP, Sheridan JF, 2011. \u03b2-Adrenergic receptor antagonism prevents anxiety-like behavior and microglial reactivity induced by repeated social defeat. J. Neurosci. 31, 6277\u20136288.","DOI":"10.1523\/JNEUROSCI.0450-11.2011"},{"key":"10.1016\/j.schres.2019.08.005_bb0185","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.2147\/NDT.S64236","article-title":"Profile of minocycline and its potential in the treatment of schizophrenia","volume":"10","author":"Zhang","year":"2014","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"9","key":"10.1016\/j.schres.2019.08.005_bb0190","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1038\/sj.npp.1301313","article-title":"Minocycline attenuates hyperlocomotion and prepulse inhibition deficits in mice after administration of the NMDA receptor antagonist dizocilpine","volume":"32","author":"Zhang","year":"2007","journal-title":"Neuropsychopharmacology"},{"issue":"17","key":"10.1016\/j.schres.2019.08.005_bb0195","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.pnpbp.2018.04.004","article-title":"Minocycline adjunctive treatment to risperidone for negative symptoms in schizophrenia: association with pro-inflammatory cytokine levels","volume":"85","author":"Zhang","year":"2018","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"8","key":"10.1016\/j.schres.2019.08.005_bb0200","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1017\/S0033291712002590","article-title":"Cigarette smoking, psychopathology and cognitive function in first-episode drug-na\u00efve patients with schizophrenia: a case-control study","volume":"43","author":"Zhang","year":"2013","journal-title":"Psychol. Med."},{"issue":"1","key":"10.1016\/j.schres.2019.08.005_bb0205","first-page":"1","article-title":"The importance of early identification and treatment in negative symptoms of schizophrenia","volume":"48","author":"Zhao","year":"2015","journal-title":"Chinese Journal of Psychiatry"},{"key":"10.1016\/j.schres.2019.08.005_bb0210","first-page":"166","article-title":"Neonatal intrahippocampal injection of lipopolysaccharide induces deficits in social behavior and prepulse inhibition and microglial activation in rats: implication for a new schizophrenia animal model","volume":"38","author":"Zhu","year":"2014","journal-title":"Brain BehavImmun"},{"key":"10.1016\/j.schres.2019.08.005_bb0215","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.neuroscience.2014.01.021","article-title":"Minocycline alleviates behavioral deficits and inhibits microglial activation induced by intrahippocampal administration of granulocyte-macrophage colony-stimulating factor in adult rats","volume":"266","author":"Zhu","year":"2014","journal-title":"Neuroscience"}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996419303469?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996419303469?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:34:14Z","timestamp":1760297654000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996419303469"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":42,"alternative-id":["S0920996419303469"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2019.08.005","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of minocycline on amelioration of cognitive deficits and pro-inflammatory cytokines levels in patients with schizophrenia","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2019.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}